<h3>涨幅榜</h3>
<ul>
<li><strong>百时美施贵宝公司 Celegne 有条件价值权</strong> (NYSE: CELGR) 的股票在周五的常规交易中上涨了 30.0%，至$0.07。</li>
<li><strong>Can Fite Biofarma</strong> (AMEX: CANF) 的股票上涨了 29.17%，至$0.23。其流通股的市场价值为 300 万美元。</li>
<li><strong>格林威治生命科学</strong> (NASDAQ: GLSI) 的股票上涨了 25.21%，至$21.55。其流通股的市场价值为 2.3 亿美元。</li>
<li><strong>GridAI Technologies</strong> (NASDAQ: GRDX) 的股票上涨了 18.08%，至$3.01。其流通股的市场价值为 850 万美元。</li>
<li><strong>Inhibikase Therapeutics</strong> (NASDAQ: IKT) 的股票上涨了 16.31%，至$1.92。其流通股的市场价值为 2 亿美元。</li>
<li><strong>SeaStar Medical Holding</strong> (NASDAQ: ICU) 的股票上涨了 15.24%，至$0.28。其流通股的市场价值为 870 万美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) 的股票在周五的常规交易中下跌了 18.5%，至$1.93。其流通股的市场价值为 240 万美元。</li>
<li><strong>ProPhase Labs</strong> (NASDAQ: PRPH) 的股票下跌了 15.47%，至$0.52。其流通股的市场价值为 250 万美元。</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) 的股票下跌了 14.25%，至$21.09。该公司的市值为 121 亿美元。</li>
<li><strong>Q/C Technologies</strong> (NASDAQ: QCLS) 的股票下跌了 11.12%，至$4.56。该公司的市值为 2130 万美元。</li>
<li><strong>Propanc Biopharma</strong> (NASDAQ: PPCB) 的股票下跌了 10.44%，至$0.59。其流通股的市场价值为 880 万美元。</li>
<li><strong>Akanda</strong> (NASDAQ: AKAN) 的股票下跌了 10.29%，至$0.45。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

DRMA

PRPH

<p>在周五的盘中交易中，几只医疗保健股票经历了显著的波动。值得注意的涨幅股票包括百时美施贵宝的 Celegne 附带价值权、Can Fite Biofarma 和格林威治生命科学，分别上涨了 30%、29.17% 和 25.21%。相反，Dermata Therapeutics 和 ProPhase Labs 则是下跌的股票，分别下跌了 18.5% 和 15.47%。本文由 Benzinga 的自动内容引擎生成，并经过编辑审核</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>涨幅榜</h3>
</div><ul>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) shares moved upwards by 30.0% to $0.07 during Friday's regular session.</li>
<li><strong>Can Fite Biofarma</strong> (AMEX: CANF) stock moved upwards by 29.17% to $0.23. The market value of their outstanding shares is at $3.0 million.</li>
<li><strong>Greenwich LifeSciences</strong> (NASDAQ: GLSI) shares moved upwards by 25.21% to $21.55. The market value of their outstanding shares is at $230.0 million.</li>
<li><strong>GridAI Technologies</strong> (NASDAQ: GRDX) shares rose 18.08% to $3.01. The market value of their outstanding shares is at $8.5 million.</li>
<li><strong>Inhibikase Therapeutics</strong> (NASDAQ: IKT) shares rose 16.31% to $1.92. The market value of their outstanding shares is at $200.0 million.</li>
<li><strong>SeaStar Medical Holding</strong> (NASDAQ: ICU) shares increased by 15.24% to $0.28. The market value of their outstanding shares is at $8.7 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>百时美施贵宝公司 Celegne 有条件价值权</strong> (NYSE: CELGR) 的股票在周五的常规交易中上涨了 30.0%，至$0.07。</li>
<li><strong>Can Fite Biofarma</strong> (AMEX: CANF) 的股票上涨了 29.17%，至$0.23。其流通股的市场价值为 300 万美元。</li>
<li><strong>格林威治生命科学</strong> (NASDAQ: GLSI) 的股票上涨了 25.21%，至$21.55。其流通股的市场价值为 2.3 亿美元。</li>
<li><strong>GridAI Technologies</strong> (NASDAQ: GRDX) 的股票上涨了 18.08%，至$3.01。其流通股的市场价值为 850 万美元。</li>
<li><strong>Inhibikase Therapeutics</strong> (NASDAQ: IKT) 的股票上涨了 16.31%，至$1.92。其流通股的市场价值为 2 亿美元。</li>
<li><strong>SeaStar Medical Holding</strong> (NASDAQ: ICU) 的股票上涨了 15.24%，至$0.28。其流通股的市场价值为 870 万美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) stock fell 18.5% to $1.93 during Friday's regular session. The market value of their outstanding shares is at $2.4 million.</li>
<li><strong>ProPhase Labs</strong> (NASDAQ: PRPH) stock declined by 15.47% to $0.52. The market value of their outstanding shares is at $2.5 million.</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) stock decreased by 14.25% to $21.09. The company's market cap stands at $12.1 billion.</li>
<li><strong>Q/C Technologies</strong> (NASDAQ: QCLS) stock decreased by 11.12% to $4.56. The company's market cap stands at $21.3 million.</li>
<li><strong>Propanc Biopharma</strong> (NASDAQ: PPCB) stock decreased by 10.44% to $0.59. The market value of their outstanding shares is at $8.8 million.</li>
<li><strong>Akanda</strong> (NASDAQ: AKAN) stock fell 10.29% to $0.45.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) 的股票在周五的常规交易中下跌了 18.5%，至$1.93。其流通股的市场价值为 240 万美元。</li>
<li><strong>ProPhase Labs</strong> (NASDAQ: PRPH) 的股票下跌了 15.47%，至$0.52。其流通股的市场价值为 250 万美元。</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) 的股票下跌了 14.25%，至$21.09。该公司的市值为 121 亿美元。</li>
<li><strong>Q/C Technologies</strong> (NASDAQ: QCLS) 的股票下跌了 11.12%，至$4.56。该公司的市值为 2130 万美元。</li>
<li><strong>Propanc Biopharma</strong> (NASDAQ: PPCB) 的股票下跌了 10.44%，至$0.59。其流通股的市场价值为 880 万美元。</li>
<li><strong>Akanda</strong> (NASDAQ: AKAN) 的股票下跌了 10.29%，至$0.45。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

12 只医疗保健股票在周五盘中交易时出现波动